Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies

Analytical Biochemistry

Volumn 343, Issue 1, 2005, Pages 66-75

  Jones, Paul D ^a   Wolf, Nicola M ^a,b   Morisseau, Christophe ^a   Whetstone, Paul ^a   Hock, Bertold ^b   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Fluorescent substrate; Kinetic assay; Soluble epoxide hydrolase; Cyanocarbonate; Cyanoester

Indexed keywords

FLUORESCENCE; HYDROLASES; MAMMALS; RADIOACTIVITY; SPECTROPHOTOMETERS; SPECTROPHOTOMETRY; SUBSTRATES;

EPOXIDE HYDROLASES; FLUORESCENT ASSAYS; FLUORESCENT SIGNALS; KINETIC ASSAY; POTENTIAL SUBSTRATE; RECOMBINANT ENZYMES; SPECTROPHOTOMETRIC ASSAYS; STRUCTURE ACTIVITY RELATIONSHIPS;

ENZYME INHIBITION;

EPOXIDE; EPOXIDE HYDROLASE;

ARTICLE; COST BENEFIT ANALYSIS; ENZYME INHIBITION; FLUORESCENCE; HYDROLYSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; STRUCTURE ACTIVITY RELATION;

MAMMALIA; MURINAE;

EID: 22144444583     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2005.03.041     Document Type: Article

References (33)

1. M. Arand, D.F. Grant, J.K. Beetham, T. Friedberg, F. Oesch, and B.D. Hammock Sequence similarity of mammalian epoxide hydrolases to the bacterial haloalkane dehalogenase and other related proteins: implication for the potential catalytic mechanism of enzymatic epoxide hydrolysis FEBS Lett. 338 1994 251 256
2. F. Oesch Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds Xenobiotica 3 1973 305 340
3. D.C. Zeldin, J. Kobayashi, J.R. Falck, B.S. Winder, B.D. Hammock, J.R. Snapper, and J.H. Capdevila Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase J. Biol. Chem. 268 1993 6402 6407
4. Z. Yu, F. Xu, L.M. Huse, C. Morisseau, A.J. Draper, J.W. Newman, C. Parker, L. Graham, M.M. Engler, B.D. Hammock, D.C. Zeldin, and D.L. Kroetz Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids Circ. Res. 87 2000 992 998
5. M.F. Moghaddam, D.F. Grant, J.M. Cheek, J.F. Greene, K.C. Williamson, and B.D. Hammock Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase Nat. Med. 3 1997 562 566
6. J.F. Greene, K.C. Williamson, J.W. Newman, C. Morisseau, and B.D. Hammock Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification Arch. Biochem. Biophys. 376 2000 420 432
7. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase J. Lipid Res. 41 2000 163 181
8. I. Fleming Cytochrome P450 enzymes in vascular homeostasis Circ. Res. 89 2001 753 762
9. C.L. Oltman, N.L. Weintraub, M. VanRollins, and K.C. Dellsperger Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation Circ. Res. 83 1998 932 939
10. B. Fisslthaler, R. Popp, L. Kiss, M. Potente, D.R. Harder, I. Fleming, and R. Busse Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 1999 493 497
11. J.D. Imig, X. Zhao, J.H. Capdevila, C. Morisseau, and B.D. Hammock Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension Hypertension 39 2002 690 694
12. X. Zhao, T. Yamamoto, J.W. Newman, I.H. Kim, T. Watanabe, B.D. Hammock, J. Stewart, J.S. Pollock, D.M. Pollock, and J.D. Imig Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage J. Am. Soc. Nephrol. 15 2004 1244 1253
13. C. Morisseau, G. Du, J.W. Newman, and B.D. Hammock Mechanism of mammalian soluble epoxide hydrolase inhibition by chalcone oxide derivatives Arch. Biochem. Biophys. 356 1998 214 228
14. C. Morisseau, M.H. Goodrow, D. Dowdy, J. Zheng, J.F. Greene, J.R. Sanborn, and B.D. Hammock Potent urea and carbamate inhibitors of soluble epoxide hydrolases Proc. Natl. Acad. Sci. USA 96 1999 8849 8854
15. C. Morisseau, M.H. Goodrow, J.W. Newman, C.E. Wheelock, D.L. Dowdy, and B.D. Hammock Structural refinement of inhibitors of urea-based soluble epoxide hydrolases Biochem. Pharmacol. 63 2002 1599 1608
16. Y. Nakagawa, C.E. Wheelock, C. Morisseau, M.H. Goodrow, B.G. Hammock, and B.D. Hammock 3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues Bioorg. Med. Chem. Lett. 8 2000 2663 2673
17. N.R. McElroy, P.C. Jurs, C. Morisseau, and B.D. Hammock QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds J. Med. Chem. 46 2003 1066 1080
18. I.H. Kim, C. Morisseau, T. Watanabe, and B.D. Hammock Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility J. Med. Chem. 47 2004 2110 2122
19. E.C. Dietze, E. Kuwano, and B.D. Hammock Spectrophotometric substrates for cytosolic epoxide hydrolase Anal. Biochem. 216 1994 176 187
20. K. Doderer, S. Lutz-Wahl, B. Hauer, and R.D. Schmid Spectrophotometric assay for epoxide hydrolase activity toward any epoxide Anal. Biochem. 321 2003 131 134
21. K. Doderer, and R.D. Schmid Fluorometric assay for determining epoxide hydrolase activity Biotechnol. Lett. 26 2004 835 839
22. C. Mateo, A. Archelas, and R. Furstoss A spectrophotometric assay for measuring and detecting an epoxide hydrolase activity Anal. Biochem. 314 2003 135 141
23. F. Badalassi, D. Wahler, G. Klein, P. Crotti, and J.L. Reymond A versatile periodate-coupled fluorogenic assay for hydrolytic enzymes Angewandte Chemie-Intl. Ed. 39 2000 4067 4070
24. C.E. Wheelock, A.M. Wheelock, R. Zhang, J.E. Stok, C. Morisseau, S.E. Le Valley, C.E. Green, and B.D. Hammock Evaluation of α-cyanoesters as fluorescent substrates for examining interindividual variation in general and pyrethroid-selective esterases in human liver microsomes Anal. Biochem. 2003 208 222
25. G. Shan, and B.D. Hammock Development of sensitive esterase assays based on α-cyano-containing esters Anal. Biochem. 299 2001 54 62
26. R. Zhang, K.D. Kang, G. Shan, and B.D. Hammock Design, synthesis, and evaluation of novel P450 fluorescent probes bearing s-cyanoether Tetrahedron Lett. 2003 4331 4334
27. A.B. Charette, C. Molinaro, and C. Brochu Catalytic asymmetric cyclopropanation of allylic alcohols with titanium-TADDOLate: scope of the cyclopropanation reaction J. Am. Chem. Soc. 123 2001 12168 12175
28. N. Ragoussis Modified Knoevenagel condensations: synthesis of (E)-3-alkenoic acids Tetrahedron Lett. 28 1987 93 96
29. D.F. Grant, D.H. Storms, and B.D. Hammock Molecular cloning and expression of murine liver soluble epoxide hydrolase J. Biol. Chem. 268 1993 17628 17633
30. J.K. Beetham, T. Tian, and B.D. Hammock cDNA cloning and expression of a soluble epoxide hydrolase from human liver Arch. Biochem. Biophys. 305 1993 197 201
31. R.N. Wixtrom, M.H. Silva, and B.D. Hammock Affinity purification of cytosolic epoxide hydrolase using derivatized epoxy-activated Sepharose gels Anal. Biochem. 169 1988 71 80
32. M.K. Dhaon, R.K. Olsen, and K. Ramasamy Esterification of N-protected α-amino acids with alcohol/carbodiimide/4-(dimethylamino)pyridine: racemization of aspartic and glutamic acid derivatives J. Organic Chem. 47 1982 1962 1965
33. C. Morisseau, and B.D. Hammock Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles Annu. Rev. Pharmacol. Toxicol. 45 2005 311 333